Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19

NCT04410354 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Stopped Failure to meet primary endpoint

Conditions

COVID-19

Interventions

DRUG: Merimepodib
DRUG: Matching Placebo
DRUG: Remdesivir

Sponsor

ViralClear Pharmaceuticals, Inc.